Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation.

MLA

Ramos, Marcelo Cristiano de Azevedo, et al. “Cost Effectiveness of the Cancer Prevention Program for Carriers of the BRCA1/2 Mutation.” Revista de Saude Publica, vol. 52, Nov. 2018, p. 94. EBSCOhost, https://doi.org/10.11606/S1518-8787.2018052000643.

APA

Ramos, M. C. de A., Folgueira, M. A. A. K., Maistro, S., Campolina, A. G., Soárez, P. C. de, Bock, G. H. de, Novaes, H. M. D., & Diz, M. D. P. E. (2018). Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation. Revista de Saude Publica, 52, 94. https://doi.org/10.11606/S1518-8787.2018052000643

Chicago

Ramos, Marcelo Cristiano de Azevedo, Maria Aparecida Azevedo Koike Folgueira, Simone Maistro, Alessandro Gonçalves Campolina, Patricia Coelho de Soárez, Geertruida Hendrika de Bock, Hillegonda Maria Dutilh Novaes, and Maria Del Pilar Estevez Diz. 2018. “Cost Effectiveness of the Cancer Prevention Program for Carriers of the BRCA1/2 Mutation.” Revista de Saude Publica 52 (November): 94. doi:10.11606/S1518-8787.2018052000643.